technetium tc-99m tetrofosmin kit
Trade name: Myoview
Small moleculeapproved
Approved
Feb 9, 1996
Clinical trial activity
3 trials · 3 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
1
Earliest trial started Jul 1, 2006 (NCT00381316)
Timeline
1990s
- Feb 9, 1996
General Electric — Earliest FDA Approval
- Feb 9, 1996
General Electric — NDA Secondary Org
- Feb 9, 1996
General Electric — NDA Organization
- Feb 9, 1996
Medi-Physics — Marketing Organization
Indications
Approved for
Studied for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedFeb 9, 1996
Chemistry & pharmacology
- Mol. weight
- 480.46 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2110566 ↗
- ChEMBLCHEMBL1200857 ↗
Also known as
- 99mtc-tetrafosmin
- 99mtc tetrofosmin
- 99mtc tetrofosmin
- 99mtc-tetrofosmin
- myoview
- myoview
- myoview
- myoview
- myoview
- myoview 30ml
- myoview 30ml
- ppn1011
- ppn-1011
- tc-99m-ppn1011
- tc99m tetrafosmin
- tc-99m tetrofosmin
- tc-99m tetrofosmin
- tc-99m-tetrofosmin
- tc99m tetrofosmin
- technetium(1+)-99tc, bis(6,9-bis(2-ethoxyethyl)-3,12-dioxa-6,9-diphosphatetradecane-.kappa.p,.kappa.p')dioxo-, (oc-6-11)-
- technetium (99mtc) tetrofosmin
- technetium (99mtc) tetrofosmin
- technetium (99mtc) tetrofosmin
- technetium-99m-tetrofosmin
- technetium-99 tetrofosmin
- technetium-99 tetrofosmin
- technetium tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane
- technetium tc 99m tetrofosmin
- technetium tc 99m tetrofosmin
- technetium tc 99m tetrofosmin
- technetium tc 99m tetrofosmin
- technetium tc-99m tetrofosmin
- technetium tc-99m tetrofosmin
- technetium tc-99m tetrofosmin
- technetium tc-99m tetrofosmin
- technetium tc-99m tetrofosmin kit
- technetium tc-99m tetrofosmin kit
- technetium tc-99m tetrofosmin kit
- technetium tc-99m tetrofosmin kit
- technetium tc-99m tetrofosmin kit
- technetium tetrofosmin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01347710 | Phase 3 | Jun 1, 2011 | Lantheus Medical Imaging |
| NCT01334918 | Phase 2 | Apr 1, 2011 | Astellas |
| NCT00381316 | Phase 4 | Jul 1, 2006 | General Electric |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 1 | 1 | 2011 |
| General Electric | For profit | 1 | 1 | 1 | 2006 |
| Lantheus Medical Imaging | For profit | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| General Electric | For profit | NDA2 | Feb 9, 1996 |
| General Electric | For profit | NDA | Feb 9, 1996 |
| Medi-Physics | For profit | MKTG | Feb 9, 1996 |